Lipitor Patent Battle: Pfizer Plots New Course In Suit With Apotex
Two years ago, Pfizer inked a settlement with Ranbaxy, the first ANDA filer for generic Lipitor, that it believed would prevent generic competition in the U.S. until November 2011
Two years ago, Pfizer inked a settlement with Ranbaxy, the first ANDA filer for generic Lipitor, that it believed would prevent generic competition in the U.S. until November 2011